MSON has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
MSON has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Net Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities minus Total Liabilities minus Minority Interest and then divided by Shares Outstanding (EOP). Misonix's Net Cash per Share for the quarter that ended in Jun. 2021 was $-1.87.
The historical rank and industry rank for Misonix's Net Cash per Share or its related term are showing as below:
During the past 13 years, the highest Price-to-Net-Cash Ratio of Misonix was 86.82. The lowest was 0.00. And the median was 10.67.
The historical data trend for Misonix's Net Cash per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Misonix Annual Data | |||||||||||||||||||||
Trend | Jun12 | Jun13 | Jun14 | Jun15 | Jun16 | Jun17 | Jun18 | Jun19 | Jun20 | Jun21 | |||||||||||
Net Cash per Share | Get a 7-Day Free Trial | 0.68 | 0.67 | -0.04 | -1.10 | -1.87 |
Misonix Quarterly Data | ||||||||||||||||||||
Sep16 | Dec16 | Mar17 | Jun17 | Sep17 | Dec17 | Mar18 | Jun18 | Sep18 | Dec18 | Mar19 | Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | |
Net Cash per Share | Get a 7-Day Free Trial | -1.10 | -1.36 | -1.30 | -1.59 | -1.87 |
For the Medical Devices subindustry, Misonix's Price-to-Net-Cash, along with its competitors' market caps and Price-to-Net-Cash data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Devices & Instruments industry and Healthcare sector, Misonix's Price-to-Net-Cash distribution charts can be found below:
* The bar in red indicates where Misonix's Price-to-Net-Cash falls into.
In the calculation of a company's Net Cash per Share, assets other than cash and short term investments are considered to be worth nothing. But the company has to pay its debt and other liabilities in full. This is an extremely conservative way of valuation. Most companies have negative Net Cash per Share. But sometimes a company's price may be lower than its net-cash.
Misonix's Net Cash per Share for the fiscal year that ended in Jun. 2021 is calculated as
Net Cash per Share (A: Jun. 2021 ) | |||||||
= | (Cash, Cash Equivalents, Marketable Securities | - | Total Liabilities | - | Minority Interest) | / | Shares Outstanding (EOP) |
= | (31.046 | - | 63.661 | - | 0) | / | 17.41 |
= | -1.87 |
Misonix's Net Cash per Share for the quarter that ended in Jun. 2021 is calculated as
Net Cash per Share (Q: Jun. 2021 ) | = | (Cash, Cash Equivalents, Marketable Securities | - | Total Liabilities | - | Minority Interest) | / | Shares Outstanding (EOP) |
= | (31.046 | - | 63.661 | - | 0) | / | 17.41 |
= | -1.87 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Misonix (NAS:MSON) Net Cash per Share Explanation
Ben Graham invested in situations where the company's stock price was lower than its net-cash. He assigned some value to the company's other current asset. The value is called Net Current Asset Value (NCAV). One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham's strategy produced similar results.
You can find companies that are traded below their Net Current Asset Value (NCAV) with our Net-Net screener.
Thank you for viewing the detailed overview of Misonix's Net Cash per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
Paul A Laviolette | director | ONE BOSTON PLACE, 201 WASHINGTON STREET, SUITE 3900, BOSTON MA 02108 |
Sharon W Klugewicz | officer: Chief Operating Officer | 3661 HORSEBLOCK ROAD, MEDFORD NY 11763 |
Thomas M Patton | director | C/O OSTEOTCH INC., 51 JAMES WAY, EATONTOWN NJ 07724 |
Joseph P Dwyer | officer: Chief Financial Officer | 3 CORDWOOD COURT, E. NORTHPORT NY 11731 |
Gwendolyn A Watanabe | director | C/O SARATOGA VENTURES, 210 ALMENDRA AVENUE, LOS GATOS CA 95030 |
Linwood A. Staub | officer: Sr. VP Wound | 8023 VANTAGE DRIVE SAN ANTONIO TX 78230 |
Stavros G. Vizirgianakis | director, officer: CEO | 1/16-18 TENNYSON ST., WILLIAMSTOWN NORTH, VICTORIA CA 3016 |
Robert S Ludecker | officer: SVP Sales - Surgical | 4 WILDBRIAR COURT MOUNT SINAI NY 11766 |
Allan Richard Staley | officer: President | C/O SOLSYS MEDICAL, LLC 600 THIMBLE SHOALS BLVD., SUITE 200 NEWPORT NEWS VA 23606 |
Michael Koby | director | C/O 1315 CAPITAL 2929 WALNUT STREET, SUITE 1240 PHILADELPHIA PA 19104 |
1315 Capital Management, Llc | 10 percent owner | 2929 WALNUT STREET SUITE 1240 PHILADELPHIA PA 19104 |
Sv Life Sciences Fund Vi (gp), L.p. | 10 percent owner | ONE BOSTON PLACE, 201 WASHINGTON STREET, SUITE 3900, BOSTON MA 02108 |
Svlsf Vi, Llc | 10 percent owner | ONE BOSTON PLACE, 201 WASHINGTON STREET, SUITE 3900, BOSTON MA 02108 |
Sv Life Sciences Fund Vi Strategic Partners, L.p. | 10 percent owner | C/O SV LIFE SCIENCES ADVISERS, LLC, ONE BOSTON PLACE, SUITE 3900, BOSTON MA 02108 |
1315 Capital, L.p. | 10 percent owner | 3020 MARKET STREET, SUITE 104 PHILADELPHIA PA 19104 |
From GuruFocus
By Business Wire Business Wire • 07-31-2021
By Marketwired Marketwired • 07-29-2021
By GF Value GF Value • 03-31-2021
By Marketwired Marketwired • 05-22-2020
By Marketwired Marketwired • 07-30-2020
By Marketwired Marketwired • 11-12-2020
By Marketwired Marketwired • 03-04-2021
By Marketwired Marketwired • 12-18-2020
By Marketwired Marketwired • 09-09-2020
By Marketwired Marketwired • 06-15-2020
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.